Vaccine maker Serum Institute of India's CEO Adar Poonawalla said the Oxford Covid-19 vaccine should be available for healthcare workers

New Delhi: Vaccine maker Serum Institute of India's CEO Adar Poonawalla said the Oxford Covid-19 vaccine should be available for healthcare workers and elderly people by around February 2021 and by April for the general public, and will be priced at a maximum of Rs 1,000 for two necessary doses for the public, depending on the final trial results and regulatory approvals.

Probably by 2024, every Indian will get vaccinated, he said.

Adar Poonawalla"It will probably take two or three years for every Indian to get inoculated, not just because of the supply constraints but because you need the budget, the vaccine, logistics, infrastructure and then, people should be willing to take the vaccine. So these are the factors that lead up to being able to vaccinate 80-90 per cent of the population.

"It will be 2024 for everybody, if willing to take a two-dose vaccine, to be vaccinated," Poonawalla said.  

Asked at what price the public will get it, he said it will be around USD 5-6 per dose with an MRP of around Rs 1,000 for the two necessary doses.

Covid-19 vaccine

"The government of India will be getting it at a far cheaper price at around USD 3-4, because it will be buying in a large volume and get access to the price that is similar to what COVAX has got. We are still pricing it far cheaper and more affordable than other vaccines we have in the market today," Poonawalla said.

Children would have to wait a little longer till the safety data is out, but the good news is that Covid-19 is not so bad and serious for them, Poonawalla said.

"We want to vaccinate the elderly people and others who are the most vulnerable first. Once we have enough safety data to go in on children, we can recommend it for children too," he said.

Poonawalla said the Oxford vaccine is affordable, safe and stored at a temperature of two to eight degrees Celsius, which is an ideal temperature for it to be stored in the cold storages of India.

Covid-19 vaccineHe said the SII plans to make about 10 crore doses per month from February.

As regards how many doses would be provided to India, Poonawalla said talks are still going on and no agreement has been arrived at in this regard.

Poonawalla said 30-40 crore doses of the Oxford vaccine will be available by the first quarter of 2021.